Skip to main content

Table 4 Association between laboratory biomarkers and degree of asthma severity and degree of asthma control in different phenotypes (allergic march and cough phenotypes)

From: Evaluation of serum levels of interferon beta and nucleotide binding and oligomerization domain 2 gene polymorphism in children with cough asthma phenotype: a case–control study

Groups

Serum eosinophilic

percentage

Serum IgE

Serum IFN-B

Median (min–max)

P value

Median (min–max)

P value

Median (min–max)

P value

Asthma severity

Allergic march

Mild asthma

5.64 (1.17–10.53)

KW = 2.7

P = 0.26

76 (3.30–532)

KW = 5

P = 0.08

18.80 (5.70–41.30)

KW = 0.62

P = 0.73

Moderate asthma

5.08 (0.53–13.04)

181 (6.20–500)

20.20 (8.35–64.00)

Severe asthma

7.54 (4.14–13.18)

65.30 (32–154)

21.40 (11.30–46.80)

Cough phenotype

Mild asthma

2.75 (1.69–9.03)

Z = 0.29

P = 0.76

440 (42.70–688)

Z = 1.0

P = 0.32

11.50 (7.330.8)

Z = 2.1

P = 0.03*

Moderate asthma

3.45 (0.01–19.24)

83.70 (1.36–520)

21.60 (1.76–109)

Asthma control

Allergic march

Controlled

4.53 (1.78–10.49)a

KW = 7.45

P = 0.02*

164.00 (29.40–500.00)

KW = 4.01

P = 0.13

18.80 (5.70–62.20)

KW = 1.21

P = 0.54

Partially controlled

5.45 (0.53–8.56)

231.00 (3.30–532.00)

23.60 (8.35–64.00)

Uncontrolled

6.91 (1.75–13.18)a

85.10 (6.20–483.80)

18.20 (9.50–46.90)

Cough phenotype

Controlled

2.87 (0.01–19.24)

KW = 2.9

P = 0.23

46.00 (3.78–520.00)

KW = 4.1

P = 0.12

21.55 (4.43–48.90)

KW = 1.5

P = 0.47

Partially controlled

4.45 (0.01–17.81)

72.80 (1.36–506)

21.50 (7.30–109)

Uncontrolled

3.31 (0.65–10.55)

391.00 (10.97–688)

13.15 (1.76–46)

  1. aSignificant between controlled and uncontrolled
  2. * significant p ≤ 0.05